Hagens Berman Informs Zynex Investors of Class Action Lawsuit and Lead Plaintiff Deadline Hagens Berman is notifying Zynex investors regarding a class action lawsuit alleging fraudulent practices and a crucial deadline for lead plaintiffs.

Hagens Berman Informs Zynex Investors of Class Action Lawsuit and Lead Plaintiff Deadline #USA #San_Francisco #Zynex #Hagens_Berman #ZYXI

Investors Alert: Zynex Securities Class Action and April Lead Plaintiff Deadline Hagens Berman is informing Zynex investors about a class action lawsuit concerning alleged securities fraud, with a deadline for lead plaintiff applications approaching soon.

Investors Alert: Zynex Securities Class Action and April Lead Plaintiff Deadline #USA #Securities_Class_Action #Zynex #Colorado #ZYXI

Trade Alerts, Monday December 16, 2025 – Crystal Equity Research

Small-cap stocks gapping down in trading, Tue Dec 16th - #VBIX #SVRE #DXST #CVKD #ZYXI #LWLG #IRBT #DFLI #CLLS #AKTX - More: crystalequityresearch.com/trade-alerts... - #smallcap

Zynex Reports Third Quarter 2025 Financial Results Zynex (NASDAQ: ZYXI) reported third quarter 2025 results for the period ended September 30, 2025. Net revenue was $13.4 million versus $50.0 million year‑ago. The company reported a net loss of ($42.9) million, or ($1.42) per share, and an Adjusted EBITDA loss of ($12.3) million. Management recorded a $30.7 million non-cash impairment tied to goodwill, intangibles and fixed assets. Cash and cash equivalents were $13.3 million as of September 30, 2025.To address liquidity and strategic options, Zynex engaged Province, LLC, formed a Special Committee chaired by Paul Aronzon, entered a 30‑day grace period and did not make a $1.5 million interest payment on $60 million convertible notes due May 2026, and is discussing restructuring with note holders.

#ZYXI Zynex Reports Third Quarter 2025 Financial Results

www.stocktitan.net/news/ZYXI/zynex-reports-...

Leading Indicators, Thursday September 25, 2025 – Crystal Equity Research

Small-cap stocks with declining money flow, Thu Sept 25th - #MTNB #DSS #ZYXI #UNIT #TRUE #SCVL #PGEN #OSS #NBN #INKT #DYN #CAC #BASE #ACB #USNA #SFL #PHR #NLOP #LUXE #HE #BAK #ACCO - More: crystalequityresearch.com/leading-indi... - #smallcap

Leading Indicators, Monday August 4, 2025 – Crystal Equity Research

Small-cap stocks with strong volume gains, Mon Aug 4th - #ZYXI #XCUR #PPIH #NAAS #LFMD #INMP #GP #EVTV #DRCI #COMM #BTAI #ATLX #SCS #LUXE #ELME #DAO #CCO - More: crystalequityresearch.com/leading-indi... - #smallcap

BREAKING NEWS: ( NASDAQ: #ZYXI ) Expected earnings - Zynex Inc.

Zynex Earnings: Revenue Plunges 55% as New CEO Unveils Massive $40M Restructuring Plan New CEO Steven Dyson leads $40M cost-cutting initiative while advancing FDA submission for NiCO pulse oximeter. See full transformation strategy.

#ZYXI Zynex Reports Second Quarter 2025 Financial Results

www.stocktitan.net/news/ZYXI/zynex-reports-...

Zynex Announces Award of UK Patent for Non-Invasive Detection of Sepsis Zynex (NASDAQ: ZYXI) has secured UK patent 2617515 for a novel multiparameter, noninvasive sepsis monitoring device. The technology aims to address a critical global health crisis, as sepsis affects 1.7 million people annually in the US alone and causes 11 million deaths globally, with one-third of hospital deaths being sepsis-related.The device will continuously monitor physiological signals to provide early alerts about patient sepsis status, leveraging Zynex's cardiac monitoring expertise. Early detection is crucial for patient recovery, as highlighted by the Surviving Sepsis Campaign. The technology could significantly impact treatment outcomes, particularly considering that over 50% of sepsis cases are hospital-acquired and current detection methods face timing challenges.

#ZYXI Zynex Announces Award of UK Patent for Non-Invasive Detection of Sepsis

www.stocktitan.net/news/ZYXI/zynex-announce...

Investors Encouraged to Lead Class Action Against Zynex, Inc. by Schall Law Firm The Schall Law Firm has contacted investors to lead a class action lawsuit against Zynex, Inc. over alleged securities fraud, urging shareholders to join before the deadline.

Investors Encouraged to Lead Class Action Against Zynex, Inc. by Schall Law Firm #United_States #Los_Angeles #Schall_Law_Firm #Zynex #ZYXI

Zynex, Inc. Investors Urged to Discuss Legal Rights Before May 2025 Deadline Investors in Zynex, Inc. are encouraged to reach out to Levi & Korsinsky by May 19, 2025, to discuss their rights in a class action lawsuit regarding alleged securities fraud.

Zynex, Inc. Investors Urged to Discuss Legal Rights Before May 2025 Deadline #USA #New_York #Levi_&_Korsinsky #Inc. #Zynex #ZYXI

Zynex, Inc. Faces Securities Law Suit: Important Notice for Shareholders on Rights and Deadlines Zynex, Inc. is facing allegations of securities law violations. Shareholders are urged to act before the May 19, 2025 deadline to protect their rights.

Zynex, Inc. Faces Securities Law Suit: Important Notice for Shareholders on Rights and Deadlines #United_States #New_York #Inc. #Securities_Law #Zynex #ZYXI

Zynex, Inc. Under Legal Scrutiny for Alleged Securities Violations Amidst Class Action Notice Zynex, Inc. has been sued for security law violations, with shareholders urged to register before May 19, 2025. Learn more about the allegations.

Zynex, Inc. Under Legal Scrutiny for Alleged Securities Violations Amidst Class Action Notice #United_States #New_York #Gross_Law_Firm #Zynex #ZYXI

Opportunities for ZYXI Investors to Lead a Major Securities Fraud Lawsuit Against Zynex, Inc. Investors of Zynex, Inc. (NASDAQ: ZYXI) may join a securities fraud lawsuit. Act by May 19, 2025, and recover losses without any upfront costs.

Opportunities for ZYXI Investors to Lead a Major Securities Fraud Lawsuit Against Zynex, Inc. #United_States #New_York #Inc. #Rosen_Law_Firm #Zynex #ZYXI

Investors Alert: Class Action Lawsuit Against Zynex, Inc. Set to Begin by May 2025 Zynex, Inc. shareholders are reminded of a forthcoming class action lawsuit with a lead plaintiff deadline on May 19, 2025, regarding misleading statements.

Investors Alert: Class Action Lawsuit Against Zynex, Inc. Set to Begin by May 2025 #USA #New_York #Class_Action #Zynex_Inc. #ZYXI

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Small-cap stocks with declining money flow, Wed Mar 12th - #PCRX #THS #ZYXI #WNEB #VANI #TBCH #RGP #QTTB #MRTN #LTRY #KALA #IBCP #HCKT #CTKB #BIRD #AVR #SMP - More: crystalequityresearch.com/SmCpStr/ - #smallcap

Zynex Reports Fourth Quarter and Full Year 2024 Financial Results Zynex (NASDAQ: ZYXI) reported its Q4 and full-year 2024 financial results, showing mixed performance. Full-year 2024 highlights include a 4% revenue increase to $192.4 million, net income of $3.0 million (EPS $0.09), and operating cash flow of $12.7 million.However, Q4 2024 showed challenges with revenue declining to $46.0 million from $47.3 million year-over-year, resulting in a net loss of ($0.6) million. A significant development is Tricare's temporary payment suspension, affecting 20-25% of annual revenue. In response, Zynex is implementing a 15% staff reduction and other cost-cutting measures, expected to save approximately $35 million annually.The company received FDA clearance for its new TensWave device and completed positive clinical trials for the NiCO laser pulse oximeter at Duke University. For Q1 2025, Zynex projects revenue of at least $30 million with an expected loss per share of ($0.30) or better.

#ZYXI Zynex Reports Fourth Quarter and Full Year 2024 Financial Results

www.stocktitan.net/news/ZYXI/zynex-reports-...

Zynex Lands Major VA Partnership, Taps Into $112B Veterans Healthcare Market Medical device company Zynex secures strategic partnership with VA Medical Centers, gaining access to 9M+ veterans and 171 medical centers for non-opioid pain treatments.

#ZYXI Zynex Announces Partnership To Conduct Business with Veterans Affairs (VA) Medical Centers, the Largest Healthcare Network in the United States

www.stocktitan.net/news/ZYXI/zynex-announce...

Zynex Completes Breakthrough Clinical Trial for Next-Gen Laser Pulse Oximeter at Duke University | ZYXI Stock News Zynex advances towards FDA submission with innovative laser-based pulse oximeter, promising improved accuracy over traditional LED devices, especially for darker skin tones.

#ZYXI Zynex Announces Completion of Its Laser Pulse Oximetry Trial

#StockMarket #news #investing

www.stocktitan.net/news/ZYXI/zynex-announce...

Zynex Develops Laser-Based Pulse Oximeter to Address Racial Bias in Healthcare | ZYXI Stock News Zynex joins Open Oximetry Project, advancing its NiCO™ pulse oximeter with laser technology to improve accuracy across all skin tones. FDA submission imminent.

#ZYXI Zynex Announces Open Oximetry Project Membership

#news #stocks #investing

www.stocktitan.net/news/ZYXI/zynex-announce...

News; ( NASDAQ: #ZYXI ) Zynex Inc. CEO Thomas Sandgaard Discusses Significant Company Growth and Future Innovations

#StockMarket #News